Požymis
Bloody nose
Klinikinis pavadinimas: Epistaxis
Epistaxis, or nosebleed, refers to a hemorrhage localized in the nose.
Santrauka
- Taip pat vadinama
- Frequent nosebleeds, Nose bleed, Nose bleeding, Nosebleed, Nasal haemorrhage, Nasal hemorrhage
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Bloody nose, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test110 genų susiję su Bloody nose
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Bloody nose. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| APOLD1apolipoprotein L domain containing 1 | Visada | 1 ligoje |
| ATXN7L3ataxin 7 like 3 | Visada | 1 ligoje |
| BLOC1S5biogenesis of lysosomal organelles complex 1 subunit 5 | Visada | 1 ligoje |
| CEBPECCAAT enhancer binding protein epsilon | Visada | 1 ligoje |
| DTNBP1dystrobrevin binding protein 1 | Visada | 1 ligoje |
| F7coagulation factor VII | Visada | 2 ligose |
| GFI1Bgrowth factor independent 1B transcriptional repressor | Visada | 2 ligose |
| GGCXgamma-glutamyl carboxylase | Visada | 3 ligose |
| HMOX1heme oxygenase 1 | Visada | 1 ligoje |
| ITGA2Bintegrin subunit alpha 2b | Visada | 2 ligose |
| MARK2microtubule affinity regulating kinase 2 | Visada | 1 ligoje |
| OAS22'-5'-oligoadenylate synthetase 2 | Visada | 1 ligoje |
| PLCG1phospholipase C gamma 1 | Visada | 1 ligoje |
| PRKACGprotein kinase cAMP-activated catalytic subunit gamma | Visada | 1 ligoje |
| RASGRP2RAS guanyl releasing protein 2 | Visada | 1 ligoje |
| TBXA2Rthromboxane A2 receptor | Visada | 1 ligoje |
| ACVRL1activin A receptor like type 1 | Labai dažnai (80–99%) | 1 ligoje |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Labai dažnai (80–99%) | 1 ligoje |
| ENGendoglin | Labai dažnai (80–99%) | 1 ligoje |
| EPORerythropoietin receptor | Labai dažnai (80–99%) | 1 ligoje |
| FGAfibrinogen alpha chain | Labai dažnai (80–99%) | 4 ligose |
| FGBfibrinogen beta chain | Labai dažnai (80–99%) | 4 ligose |
| FGGfibrinogen gamma chain | Labai dažnai (80–99%) | 4 ligose |
| GDF2growth differentiation factor 2 | Labai dažnai (80–99%) | 1 ligoje |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Labai dažnai (80–99%) | 1 ligoje |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Labai dažnai (80–99%) | 1 ligoje |
| JAK2Janus kinase 2 | Labai dažnai (80–99%) | 1 ligoje |
| LYSTlysosomal trafficking regulator | Labai dažnai (80–99%) | 2 ligose |
| PRTN3proteinase 3 | Labai dažnai (80–99%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Labai dažnai (80–99%) | 2 ligose |
| SMAD4SMAD family member 4 | Labai dažnai (80–99%) | 2 ligose |
| ANO6anoctamin 6 | Dažnai (30–79%) | 1 ligoje |
| ATP8B1ATPase phospholipid transporting 8B1 | Dažnai (30–79%) | 1 ligoje |
| BCORBCL6 corepressor | Dažnai (30–79%) | 1 ligoje |
| F10coagulation factor X | Dažnai (30–79%) | 2 ligose |
| F11coagulation factor XI | Dažnai (30–79%) | 1 ligoje |
| F2coagulation factor II, thrombin | Dažnai (30–79%) | 2 ligose |
| F5coagulation factor V | Dažnai (30–79%) | 2 ligose |
| F8coagulation factor VIII | Dažnai (30–79%) | 3 ligose |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Dažnai (30–79%) | 1 ligoje |
Rodyti dar 70 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| GALEUDP-galactose-4-epimerase | Dažnai (30–79%) | 1 ligoje |
| GNEglucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Dažnai (30–79%) | 1 ligoje |
| GP1BAglycoprotein Ib platelet subunit alpha | Dažnai (30–79%) | 3 ligose |
| HPS4HPS4 biogenesis of lysosomal organelles complex 3 subunit 2 | Dažnai (30–79%) | 1 ligoje |
| HPS5HPS5 biogenesis of lysosomal organelles complex 2 subunit 2 | Dažnai (30–79%) | 1 ligoje |
| HPS6HPS6 biogenesis of lysosomal organelles complex 2 subunit 3 | Dažnai (30–79%) | 1 ligoje |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| LMAN1lectin, mannose binding 1 | Dažnai (30–79%) | 1 ligoje |
| LMX1BLIM homeobox transcription factor 1 beta | Dažnai (30–79%) | 1 ligoje |
| MCFD2multiple coagulation factor deficiency 2, ER cargo receptor complex subunit | Dažnai (30–79%) | 2 ligose |
| NABP1nucleic acid binding protein 1 | Dažnai (30–79%) | 1 ligoje |
| NBEAL2neurobeachin like 2 | Dažnai (30–79%) | 2 ligose |
| NPM1nucleophosmin 1 | Dažnai (30–79%) | 1 ligoje |
| NUMA1nuclear mitotic apparatus protein 1 | Dažnai (30–79%) | 1 ligoje |
| PMLPML nuclear body scaffold | Dažnai (30–79%) | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Dažnai (30–79%) | 1 ligoje |
| RARAretinoic acid receptor alpha | Dažnai (30–79%) | 1 ligoje |
| SOX17SRY-box transcription factor 17 | Dažnai (30–79%) | 1 ligoje |
| STAT3signal transducer and activator of transcription 3 | Dažnai (30–79%) | 1 ligoje |
| STAT5Bsignal transducer and activator of transcription 5B | Dažnai (30–79%) | 1 ligoje |
| STIM1stromal interaction molecule 1 | Dažnai (30–79%) | 1 ligoje |
| STXBP1syntaxin binding protein 1 | Dažnai (30–79%) | 1 ligoje |
| TBL1XR1TBL1X/Y related 1 | Dažnai (30–79%) | 1 ligoje |
| VWFvon Willebrand factor | Dažnai (30–79%) | 3 ligose |
| ZBTB16zinc finger and BTB domain containing 16 | Dažnai (30–79%) | 1 ligoje |
| ACTN1actinin alpha 1 | Kartais (5–29%) | 2 ligose |
| BLOC1S3biogenesis of lysosomal organelles complex 1 subunit 3 | Kartais (5–29%) | 1 ligoje |
| CACNA1Dcalcium voltage-gated channel subunit alpha1 D | Kartais (5–29%) | 1 ligoje |
| CDC42BPBCDC42 binding protein kinase beta | Kartais (5–29%) | 1 ligoje |
| CLCN2chloride voltage-gated channel 2 | Kartais (5–29%) | 1 ligoje |
| CYP11B1cytochrome P450 family 11 subfamily B member 1 | Kartais (5–29%) | 1 ligoje |
| CYP11B2cytochrome P450 family 11 subfamily B member 2 | Kartais (5–29%) | 1 ligoje |
| F13A1coagulation factor XIII A chain | Kartais (5–29%) | 2 ligose |
| F13Bcoagulation factor XIII B chain | Kartais (5–29%) | 1 ligoje |
| F9coagulation factor IX | Kartais (5–29%) | 1 ligoje |
| FCGR2CFc gamma receptor IIc (gene/pseudogene) | Kartais (5–29%) | 1 ligoje |
| FERMT3FERM domain containing kindlin 3 | Kartais (5–29%) | 1 ligoje |
| GIMAP5GTPase, IMAP family member 5 | Kartais (5–29%) | 1 ligoje |
| GP1BBglycoprotein Ib platelet subunit beta | Kartais (5–29%) | 2 ligose |
| HLA-Bmajor histocompatibility complex, class I, B | Kartais (5–29%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Kartais (5–29%) | 1 ligoje |
| IFNGinterferon gamma | Kartais (5–29%) | 1 ligoje |
| ITGB3integrin subunit beta 3 | Kartais (5–29%) | 2 ligose |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Kartais (5–29%) | 1 ligoje |
| LAMA3laminin subunit alpha 3 | Kartais (5–29%) | 1 ligoje |
| MYD88MYD88 innate immune signal transduction adaptor | Kartais (5–29%) | 1 ligoje |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Kartais (5–29%) | 1 ligoje |
| PRF1perforin 1 | Kartais (5–29%) | 1 ligoje |
| SBDSSBDS ribosome maturation factor | Kartais (5–29%) | 1 ligoje |
| SERPINE1serpin family E member 1 | Kartais (5–29%) | 1 ligoje |
| SLC37A4solute carrier family 37 member 4 | Kartais (5–29%) | 1 ligoje |
| TERCtelomerase RNA component | Kartais (5–29%) | 1 ligoje |
| TERTtelomerase reverse transcriptase | Kartais (5–29%) | 1 ligoje |
| TPM4tropomyosin 4 | Kartais (5–29%) | 1 ligoje |
| TRPM7transient receptor potential cation channel subfamily M member 7 | Kartais (5–29%) | 1 ligoje |
| TUBA8tubulin alpha 8 | Kartais (5–29%) | 1 ligoje |
| TUBB1tubulin beta 1 class VI | Kartais (5–29%) | 1 ligoje |
| VKORC1vitamin K epoxide reductase complex subunit 1 | Kartais (5–29%) | 1 ligoje |
| WASWASP actin nucleation promoting factor | Kartais (5–29%) | 3 ligose |
| ETV6ETS variant transcription factor 6 | Neužfiksuota | 1 ligoje |
| GATA1GATA binding protein 1 | Neužfiksuota | 2 ligose |
| GBA1glucosylceramidase beta 1 | Neužfiksuota | 1 ligoje |
| GP6glycoprotein VI platelet | Neužfiksuota | 1 ligoje |
| GP9glycoprotein IX platelet | Neužfiksuota | 1 ligoje |
| HPS1HPS1 biogenesis of lysosomal organelles complex 3 subunit 1 | Neužfiksuota | 1 ligoje |
| MYH9myosin heavy chain 9 | Neužfiksuota | 1 ligoje |
| P2RY12purinergic receptor P2Y12 | Neužfiksuota | 1 ligoje |
| PLAUplasminogen activator, urokinase | Neužfiksuota | 1 ligoje |
| RUNX1RUNX family transcription factor 1 | Neužfiksuota | 1 ligoje |
| SLFN14schlafen family member 14 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites